Extracorporeal photopheresis (ECP) is a therapeutic procedure in which leukapheresed
peripheral blood mononuclear cells are exposed to ultraviolet A in the presence of the …

Purpose Extracorporeal photopheresis (ECP) is effective for treating cutaneous T‐cell
lymphoma. In 1987, a pivotal trial showed 81% overall response rate (ORR) using outdated …

Background: This original cohort of patients with erythrodermic cutaneous T-cell lymphoma
(CTCL) was reported to have clinical improvement with photopheresis during the 12 months …

Background: Many regimens are used for cutaneous T-cell lymphoma (CTCL), but with
advanced disease response rates and patient survival are not adequate with any current …

Extracorporeal photopheresis (ECP) is an established therapy for cutaneous T-cell
lymphoma (CTCL). The objective of this study was to further explore the clinical efficacy of …

Background: Extracorporeal photochemotherapy (ECP; photopheresis) is a treatment option
for cutaneous T-cell lymphoma (CTCL). Objective: This study describes the outcomes …

Cutaneous T-cell lymphoma (CTCL) is the general term used to describe extracutaneous
non-Hodgkin's lymphomas characterized by monoclonal expansion of skin-homing …

Cutaneous T‐cell lymphoma (CTCL) is an indolent lymphoma usually of CD4+ T
lymphocytes in which the aggressive treatment for the advanced stages does not increase …

Extracorporeal photopheresis (ECP) using UVA irradiation of enriched lymphocytes in the
presence of 8-methoxypsoralen as a photoactivatable substrate was originally introduced as …

Extracorporeal photochemotherapy (ECP) is an effective treatment modality for patients with
erythrodermic myocosis fungoides (MF) and Sezary syndrome (SS). During ECP, a fraction …